Acquired resistance to the ALK inhibitor crizotinib in the absence of an ALK mutation.
作者信息
Costa Daniel B, Kobayashi Susumu
机构信息
Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
出版信息
J Thorac Oncol. 2012 Mar;7(3):623-5. doi: 10.1097/JTO.0b013e318241daab.
PMID:22334013
Abstract
摘要
Zotero 插件